Procore Technologies Inc
F:5PT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Procore Technologies Inc
F:5PT
|
US |
|
S
|
Sutro Biopharma Inc
F:S09
|
US |
|
S
|
Siav SpA
F:F4U
|
IT |
|
J
|
Jack in the Box Inc
XBER:JBX
|
US |
|
C
|
Cullen/Frost Bankers Inc
F:CFZ
|
US |
|
B
|
Basler AG
XBER:BSL
|
DE |
|
L
|
Leifheit AG
XHAM:LEI
|
DE |
|
F
|
Fuchs Se
XMUN:FPE
|
DE |
|
Neutron Holdings Inc
NASDAQ:LIME
|
US |
|
P
|
Precision BioSciences Inc
F:PBS
|
US |
|
Alligator Bioscience AB
F:7AL
|
SE |
|
QB Net Holdings Co Ltd
TSE:6571
|
JP |
|
N
|
Nabors Industries Ltd
F:NBI1
|
BM |
|
Capcom Co Ltd
F:CPK
|
JP |
|
Sutro Biopharma Inc
NASDAQ:STRO
|
US |
|
B
|
Banca Sistema SpA
F:B2S
|
IT |
Wall St Price Targets
5PT Price Targets Summary
Procore Technologies Inc
According to Wall Street analysts, the average 1-year price target for 5PT is 81.75 EUR with a low forecast of 63.9 EUR and a high forecast of 107.76 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5PT's stock price target?
Price Target
81.75
EUR
According to Wall Street analysts, the average 1-year price target for 5PT is 81.75 EUR with a low forecast of 63.9 EUR and a high forecast of 107.76 EUR.
What is the Revenue forecast for Procore Technologies Inc?
Projected CAGR
13%
Over the last 7 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 5 years is 13%.
What is the Gross Profit forecast for Procore Technologies Inc?
Projected CAGR
16%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 32%. The projected CAGR for the next 3 years is 16%.
